Democratized DNA Synthesis: A Game-Changer Against Covid-19
DNA synthesis is one of the pillars of Covid-19 research that has suffered supply disruptions…
DNA synthesis is one of the pillars of Covid-19 research that has suffered supply disruptions…
Cell and gene therapy is booming amid the ongoing pandemic, and this is driving up…
Novel immunotherapies, like T cell therapy, may have shown recent successes but they also come…
Since Germany legalized cannabis for medical use in 2017, we have frequently spoken to Peter…
Novartis’ Kymriah, one of the first CAR T-cell therapies to be approved to treat blood…
Norway has not typically been an attractive region for biotech investors, so when Masha Strømme…
For decades, Alzheimer's disease research focused on a hypothesis that has increasingly been contested. A…
While the coronavirus pandemic has shaken many industries to their core, the European medical cannabis…
Following 2018’s bumper harvest for equity funding in European biotech, 2019 proved even more lucrative,…
For Isabelle de Cremoux, CEO and Managing Partner at Seventure Partners, 2020 was going to…
The University of Cambridge is world-famous, but unlike its US equivalent, the city isn’t as…
More genomic data is produced today than ever before as it’s fundamental to the development…